ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,397Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 336

$868K Total Retail Price of All Prescriptions

Rank: 61 out of 336

578 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 578 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 14,027 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 771 605 1 1
METFORMIN HCL 556 405 2 8
LISINOPRIL 522 366 3 6
FUROSEMIDE 522 389 3 4
OMEPRAZOLE 500 389 5 3
HYDROCHLOROTHIAZIDE 469 397 6 12
LEVOTHYROXINE SODIUM 453 336 7 7
SIMVASTATIN 357 317 8 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 353 273 9 23
MELOXICAM 337 256 10 19
TRAMADOL HCL 337 310 10 20
POTASSIUM CHLORIDE 334 270 12 9
HYDROCODONE-ACETAMINOPHEN 333 201 S3 13 2
ATORVASTATIN CALCIUM 310 252 14 14
DONEPEZIL HCL 308 304 15 27
RANITIDINE HCL 281 181 16 36
PRAVASTATIN SODIUM 274 200 17 10
GABAPENTIN 261 208 18 11
METOPROLOL TARTRATE 259 203 19 16
CITALOPRAM HBR 246 194 20 21
NAMENDA 234 227 21 39
ALENDRONATE SODIUM 206 201 22 54
ATENOLOL 196 135 23 26
METOPROLOL SUCCINATE 190 183 24 15
CARVEDILOL 187 102 25 13
TAMSULOSIN HCL 179 135 26 38
WARFARIN SODIUM 176 151 27 17
SERTRALINE HCL 173 161 28 33
LOVASTATIN 160 140 29 34
GLYBURIDE 158 117 R 30 76
NEXIUM 157 121 31 24
ZOLPIDEM TARTRATE 154 121 32 18
ALLOPURINOL 153 86 33 30
CRESTOR 147 122 34 25
CELEBREX 146 125 35 105
CLOPIDOGREL 141 94 36 28
NABUMETONE 139 112 37 159
CYCLOBENZAPRINE HCL 138 98 R 38 65
CYMBALTA 135 114 39 52
AMITRIPTYLINE HCL 122 94 R 40 57
JANTOVEN 117 89 41 125
AZITHROMYCIN 117 90 41 58
SYNTHROID 111 88 43 43
KLOR-CON M20 109 80 44 51
AMLODIPINE BESYLATE-BENAZEPRIL 108 90 45 47
DIGOXIN 107 95 46 50
PANTOPRAZOLE SODIUM 107 77 46 40
PLAVIX 99 75 48 37
DIOVAN 96 86 49 31
TERAZOSIN HCL 95 94 50 166
MIRTAZAPINE 94 84 51 66
GLIMEPIRIDE 94 70 51 29
JANUVIA 92 74 53 67
CLONIDINE HCL 90 56 54 32
TRAZODONE HCL 88 45 55 46
LYRICA 86 65 56 70
KLOR-CON 10 83 75 57 75
NITROFURANTOIN 82 78 58 210
GLIPIZIDE 80 46 59 71
VERAPAMIL ER 79 70 60 95
CIPROFLOXACIN HCL 76 58 61 55
ISOSORBIDE MONONITRATE ER 73 50 62 44
ROPINIROLE HCL 73 60 62 98
ADVAIR DISKUS 72 58 64 82
PROMETHAZINE HCL 71 36 R 65 99
DIOVAN HCT 70 50 66 41
SPIRIVA 69 57 67 88
SINGULAIR 67 44 68 85
PROPRANOLOL HCL 67 48 68 101
POLYETHYLENE GLYCOL 3350 66 62 70 68
QUETIAPINE FUMARATE 64 59 71 94
SPIRONOLACTONE 64 38 71 42
SYMBICORT 63 52 73 155
NOVOLOG MIX 70-30 FLEXPEN 61 37 74 221
PREDNISONE 60 55 75 48
FLUTICASONE PROPIONATE 59 39 76 49
COMBIVENT 58 49 77 152
MECLIZINE HCL 56 47 78 96
LEVOXYL 55 43 79 180
TRICOR 54 50 80 108
HUMULIN 70-30 53 52 81 173
NOVOLIN 70-30 51 42 82 163
GLIPIZIDE ER 51 37 82 91
VENLAFAXINE HCL ER 51 33 82 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.